baber/WOPTO huggingface dataset:
Patent JP-2001522425-A (JP)
Title: 原動力発生機構及びポンピング機構
IPC: F04B17/03
Filed: 1998-03-31
Abstract: (57)【要約】
本発明の原理により、１つの好ましい実施形態において、ポンピングシステム（９０）が提供される。このシステムは管（１１２）を回転自在に支承するハウジング（１０８）を含み、複数の磁石（１１６）がこの管の回りに配設される。磁石は管を回転させる磁力を発生する。このシステムはさらに管に接続されたポンプ（９４）を含む。管が回転する際に、ポンプが機械的回転エネルギーを受け、このエネルギーがポンプを作動する。さらにシステムが流体をポンピングするように作動する時、ポンプと管を通して流体が流れるように管とポンプが相互に流体連通される。好ましくはシステム中においてポンプの吐出口末端（９８）が管に接続するので、流体はまずポンプを通り次に管を通る。
Patent MD-20010059-A (MD)
Title: Screwdriver
Inventor: VASILEVSCHII VALERIU
IPC: B25B15/02
Filed: 2001-03-12
Abstract: The invention relates to the hand tools, in particular to the demountable screwdrivers.The screwdriver contains a dielectric handle 1, into the interior cavity 2 of which there are installed elastic jaws 3 for fixation of the removable rod 4, provided with bulges 5. Into one end of the rod it is made an axial hole 6, wherein it is placed the writing element 7. The other end of the rod is made in the form of an edge 8. Onto the surface of the rectangular handle of the screwdriver it is executed a metric scale 9. Moreover, onto the surface of the removable rod of the screwdriver there are executed cuts 10.The result consists in expanding the range of technological and functional possibilities of the screwdriver.
Patent MX-152506-A (MX)
Inventor: MARKUS GERARDUS ANTHONIUS
IPC: F23R3/10
Filed: 1981-06-16
Abstract: A fuel inlet assembly for a fuel reactor which has an inner shell mounted coaxially within an outer shell, which is closed-at one axial end, the outer shell having an inlet for introducing combustion air into the annular space between the inner and outer shells, the other end of the inner shell being spaced from the inlet assembly which is mounted at the other end of the outer shell, the fuel inlet assembly including a base plate which is mountable on said other end of the outer shell, and having a fuel inlet aperture therein. A first frusto-conical inlet cone is mounted on the base plate to surround the fuel inlet aperture and a second frusto-conical inlet cone is mounted coaxially therewith by means of a plurality of circumferentially spaced wanes which extend in radial planes, the second cone overlapping the first cone, whereby a portion of the combustion air can flow through the annular space between the first and second inlet cones, with an axial component of velocity, to premix with the fuel entering at the first fuel inlet aperture.
Patent MX-158489-A (MX)
Inventor: CONRAD LUCAS JONES
IPC: A24B3/18
Filed: 1984-02-23
Abstract: A fluid pressure treating apparatus including a cylindrical tubular shell with a reciprocal spool assembly mounted for movement between a loading position outside the shell and a treating position within the shell, sealing members on said spool assembly for engaging the shell to form the pressure chamber. Conduits are provided to introduce processing fluid into the pressure chamber.
Patent NO-20072761-A (NO)
Inventor: VATNE PER A
IPC: E21B21/10
Filed: 2007-05-30
Abstract: A device for a top drive drilling machine, in which a drive shaft, which is arranged for releasable connection to a drive and to a first end portion of a drill pipe, is provided with a centre bore extending therethrough and arranged for fluid communication between the drilling mud plant and a fluid bore in the drill pipe. First and second releasable, drive-shaft-surrounding, respectively drill-string-surrounding, pressure seals and a valve which is arranged to provide, in an open position, a passage for the drill pipe or drive shaft, form a first and a second chamber. A drilling mud inlet is arranged for the second chamber and is arranged for fluid communication between the drilling mud plant and connection housing. A method for the continuous supply of drilling mud to a drill string by the use of the drilling machine.
Patent NZ-207239-A (NZ)
Title: Quinolone carboxylic acid derivatives and pharmaceutical compositions
Inventor: PETERSEN U
IPC: A61K31/495
Filed: 1984-02-22
Abstract: The invention relates to quinolone carboxylic acids, pharmaceutical compositions containing said quinolone carboxylic acids and the use of said compounds and compositions for treatment of bacterial infection. Also included in the invention are process for the manufacture of the active quinolone carboxylic acids.
Patent NZ-208076-A (NZ)
Title: Liquid applicator: sealed by distortable diaphrapm with slit
Inventor: HAMMOND G R
IPC: B65D47/42
Filed: 1984-05-07
Abstract: An applicator for applying liquids to surfaces, especially highly mobile liquids of low viscosity, the applicator comprising a cap-like body (30) in a transverse wall (50) of which is a dispensing aperture (60). An applicator pad (90) is bonded to the outside of the transverse wall and there is a diaphragm (70) on the other side of the transverse wall, covering the dispensing aperture. The diaphragm (70) has a slit (80), radially spaced from the dispensing aperture.An actuator member (100) extending through the dispensing aperture (60) rests with one end in contact with the diaphragm (70) and its other end in the applicator pad (90) so that pressure on the applicator pad (90) is transmitted via the actuator member (100) to displace the diaphragm (70) from the dispensing aperture (60) and open the slit (80).The applicator resists accidental discharge of liquid and is particularly useful for applying treatment liquidsto the leather of shoe uppers to impart a shine.
Patent NZ-214976-A (NZ)
Title: Pulsator for milking machines: control channels in communication wtih one of the control chambers in a plate cam
Inventor: ICKING F
IPC: A01J5/12
Filed: 1986-01-29
Abstract: A pulsator for milking machines has two diaphragms connected by a rod with each diaphragm dividing a pressure chamber into a processing space and a damping space. The damping spaces communicate through a channel that is provided with a throttle. The processing spaces are connected either to a source of vacuum or to the atmosphere. A switchover is attached to the rod and connects lines leading to the pulsation spaces of milking containers either to the atmosphere or to a source of vacuum. A main line is provided with a throttle. The throttles in the communicating channel and in the main line are detoured by bypasses provided with chokes that can be vacuum-activated through control channels. To improve the known pulsator by eliminating the sensitive hoses and timers and to allow adjustment of the duration of the stimulation phase with no need for a timer, the control channels are always in communication with one of the control chambers in a control disk, one chamber constantly communicating with the vacuum source and the other chambers subject to atmospheric pressure. The disk can be rotated by a transmission, which is driven by the rod as it travels back and forth, in such a way that the control channels are connected either to the control chamber that is subject to vacuum or to one of the control chambers that are subject to atmospheric pressure.
Patent NZ-221464-A (NZ)
Title: Manufacture of 1,3-glycols
Inventor: MURPHY M A
IPC: C07C29/15
Filed: 1987-08-17
Abstract: A process for manufacturing 1,3-glycols is disclosed. The process comprises reacting an epoxide with synthesis gas in an acidic medium in the presence of rhodium and a phosphine.
Patent NZ-225051-A (NZ)
Title: Aryloxyphenylthioureas, isothioureas and carbodiimides, preparation thereof, and use as a pesticide
Inventor: BOGER W
IPC: A01N47/30
Filed: 1988-06-16
Abstract: There are disclosed novel substituted aryloxyphenylthioureas, -isothioureas and -carbodiimides of the formula I 
<IMAGE>
 in which R1 represents C1-C12-alkyl, C1-C12-alkyl which is monosubstituted or polysubstituted by halogen and/or C1-C6-alkoxy, or represents C3-C8-cycloalkyl, C3-C8-cycloalkyl which is monosubstituted or polysubstituted by C1-C3-alkyl, or represents C3-C8-cycloalkyl- C1-C4-alkyl;
 R2 represents hydrogen or C1-C5-alkyl;
 R3 represents C1-C5-alkyl or C5-C6-cycloalkyl;
 R4 represents hydrogen or methyl;
 R5 represents a  &lparstr& CH=CH &rparstr& 2,  &lparstr& CH2 &rparstr& 3, &lparstr& CH2 &rparstr& 4 bridge in the 2,3- or 3,4-position;
 Z represents -NH-CS-NH-, -N=C(SR6)-NH- or -N=C=N- and
 R6 represents C1-C10-alkyl or allyl,
 and their salts with organic or inorganic acids, their preparation, intermediates for their preparation, their use in pest control, and pesticides which contain at least one compound of the formula I as active substance. The preferred field of application is the control of pests on animals and plants.
Patent NZ-247151-A (NZ)
Title: Aqueous composition for aiding release of concrete etc from moulds, containing an ester of an aliphatic carboxylic acid and a hindered polyhydric alcohol
Inventor: VAN HOORN BART
IPC: B28B7/38
Filed: 1993-03-15
Abstract: A biodegradable oil and water emulsion release composition for facilitating the unmoulding of hydraulic bonding material comprises as the oil component an ester of a hindered polyhydric alcohol having no hydrogen atoms attached to any carbon atom in a beta-position to any hydroxyl group and a straight or branched chain, saturated or unsaturated C4-C24 monocarboxylic acid. The ester may be partial and the partial ester may be alkoxylated. In a preferred embodiment also a straight or branched chain, saturated or unsaturated C8-C24 monohydric alcohol is present. Also a method of unmoulding has been described.
Patent NZ-255041-A (NZ)
Title: Preparation of a recombinant single copy polypeptide or portion thereof modified with a terminal alpha amino carbon reactive group and reactive side chain groups involving biologically added protective groups
Inventor: STOUT JAY STEWART
IPC: C07K14/47
Filed: 1993-07-13
Abstract: The present invention provides for a method of preparing a modified recombinantly produced polypeptide including a reactive side chain group and a modified N-terminal  alpha -amine group or C-terminal alpha -carboxyl group, the method comprising the steps of recombinantly forming a polypeptide having a biologically added protecting group on an N-terminal  alpha -amine group or C-terminal alpha -carboxyl group, cleaving the biologically added protecting group with a cleavage reagent to form the unprotected terminal amino acid  alpha -carbon reactive group and modifying the unprotected terminal amino acid  alpha -carbon reactive group with a chemical modifying agent to form a terminally modified polypeptide. The invention further provides for a biologically added protecting group for a recombinantly produced polypeptide comprising a peptide or amino acid, said biologically protecting group being stable under conditions for chemical protecting reactions and including an enzymatic cleavage recognition site and a chemical cleavage recognition site, wherein the recognition sites are not present in the recombinantly produced polypeptide.
Patent NZ-296748-A (NZ)
Title: Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
Inventor: MANDEL GAIL
IPC: A61K31/445
Filed: 1995-11-02
Abstract: This isolated nucleic acid molecule coding for, or complementary to, a peptide comprising an amino acid sequence corresponding to at least one peripheral nervous system specific sodium channel peptide where the sodium channel peptide has sodium channel biological activity. Also claimed are the peptide encoded by the above nucleic acid and an antibody which binds an epitope specific for the above peptide, A method of detecting one peripheral nervous system specific sodium channel peptide is claimed.
Patent NZ-332655-A (NZ)
Title: Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates
Inventor: REINER ALBERTO
IPC: A61P19/02
Filed: 1997-05-15
Abstract: A pharmaceutical formulation for oral use containing diclofenac in acid and/or salt form together with alkali metal bicarbonates or mixtures thereof and customary excipients and adjuvants characterised that the alkali metal bicarbonates are present in amount of from 20-80% by weight based on the weight of diclofenac is claimed.
Patent NZ-336876-A (NZ)
Title: Process for preparation of 4-H-4-oxo-quinolizine-3-carboxylic acid derivatives
Inventor: WANG WEI-BO
IPC: C07D455/02
Filed: 1998-02-06
Abstract: Substituted pyrazole-3-yl benzazoles of formula (I) and salts thereof wherein: R1 is H, alkyl or alkyl halide; R2 is CN, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, alkylsulphinyl, haloalkylsulphinyl, alkylsulphonyl, or haloalkylsulphonyl; R3 is H, CN, NO2, halogen, alkyl or haloalkyl; R4 is H, halogen; R5 is H, CN, halogen, alkyl, haloalkyl, alkoxy or haloalkoxy; Z is N=C(XR6)O or N=C(XR6)S, bonded to alpha by the nitrogen, oxygen or sulphur; X is a chemical bond, oxygen, sulphur, S(O), SO2, NH or N(R7);  R6 and R7 are alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cyanoalkenyl, haloalkenyl, alkinyl, cyanoalkinyl, haloalkinyl, alkoxyalkyl, haloalkoxyalkyl, alkenyloxyalkyl, alkinyloxyalkyl, cycloalkyloxyalkyl, aminoalkyl, alkylaminoalkyl, di(alkyl)aminoalkyl, alkylthioalkyl, haloalkylthioalkyl, alkenylthio alkyl, alkinylthioalkyl, alkylsulphinylalkyl, haloalkylsulphinylalkyl, alkenylsulphinylalkyl, alkinylsulphinylalkyl, alkylsulphonylalkyl, haloalkylsulphonylalkyl, alkenylsulphonylalkyl, alkinylsulphonylalkyl, hydroxycarbonylalkyl, alkoxycarbonylalkyl, which can carry a CN or alkoxycarbonyl group, alkylthiocarbonylalkyl, aminocarbonylalkyl, alkylaminocarbonylalkyl, di(alkyl)aminocarbonylalkyl, dialkylphosphonylalkyl, alkoxyiminoalkyl, alkenyloxyiminoalkyl, optionally substituted cycloalkyl, cycloalkylalkyl, phenyl, phenylalkyl, 3 to 7member heterocyclic or heterocyclylalkyl, wherein each cycloalkyl ring and each heterocyclyl ring contain a CO or CS ring member; if X is a chemical bond, O, S, NH or N(R7), R6 also being  alkylcarbonyl,  haloalkylcarbonyl,  alkoxycarbonyl,  alkylsulphonyl or  haloalkylsulphonyl; if X is a chemical bond, R6 additionally designating CN, SH, NH2, halogen, CH2CH(halogen)R8, CH=CHR8 or CH=C(halogen)R8, or R6 plus R7 designating an optionally substituted 1,3propylene, tetramethylene, pentamethylene or ethylene oxyethylene chain R8 is COOH, alkoxycarbonyl, alkylthiocarbonyl, CONH2, alkylaminocarbonyl, dialkylaminocarbonyl or dialkylphosphonyl. These substances are useful as herbicides and for the desiccation and/or defoliation of plants
Patent NZ-337904-A (NZ)
Title: cDNA characterised using microarray technique, where cDNA are digested with restriction enzymes, then ligated and amplified by PCR and finally classified according to size to assist in human genome project
Inventor: SCHMIDT GUNTER
IPC: C12Q1/6853
Filed: 1998-04-20
Abstract: A method for characterising cDNA, so that DNA may be identified, for example, from a population of DNA, which method comprises: (a) Exposing a sample comprising a population of one or more cDNA or fragments thereof to a cleavage agent which recognises a predetermined sequence and cuts at a reference site at a known displacement from the predetermined sequence proximal to an end of each cDNA or fragment thereof so as to generate a population of terminal fragments; (b) Ligating to each reference site an adaptor oligonucleotide which comprises a recognition site for a sampling cleavage agent; (c) Exposing the population of terminal fragments to a sampling cleavage agent which binds to the recognition site and cuts at a sampling site of known displacement from the recognition site so as to generate in each terminal fragment a sticky end sequence of a predetermined length of up to 6 bases, and of unknown sequence; (d) Separating the population of terminal fragments into sub-populations according to sequence length; and  (e) Determining each sticky end sequence. The method relates to a method for assaying DNA where the analysis of patterns of gene expression is required; especially analysis of gene expression in vivo.
Patent NZ-501905-A (NZ)
Title: Gravitiationally separating fines from aggregate by allowing aggregate to fall over edge of inclined bed
Inventor: WAGNER DENIS
IPC: B07B13/10
Filed: 1998-07-06
Abstract: A mixture of aggregate and fines is allowed to fall down inclined plate 11.  As the mixture falls off the end of the plate, the fines fall into space 21 on one side of a separator plate 12.  The momentum of the larger aggregate particles carries them over separator plate 12 and into space 20.  The inclined plate 11 forms a wall of space 21, while separator plate 12 forms a wall of space 20.  The gap 19 between the separator plate and the inclined plate can be varied to determine the relative sizes of the particles collected in the two spaces.
Patent NZ-502033-A (NZ)
Title: Assessing properties of meat such as the fat or lean meat content using dual energy x-ray absorption scanner
Inventor: BARTLE COLIN MURRAY
IPC: G01N23/04
Filed: 2000-06-11
Abstract: The properties of meat are assessed using a non-invasive dual-energy X-ray absorption scanner. Two images or arrays of the values representative of the intensities of the X-rays at two energy levels are produced. These are then processed to determine properties such as the chemical lean, fat percentage, weight, presence of contaminants and the tenderness of the scanned meat. The meat assessment includes a correction step to overcome unwanted instrumental effects.
Patent NZ-502463-A (NZ)
Title: 1-Phenyl vinyl substituted imidazole, triazole or tetrazole derivatives useful for controlling or preventing acute or chronic neurological disorders
Inventor: ADAM GEO
IPC: C07D249/08
Filed: 1998-08-06
Abstract: The compounds of formula (I) or their pharmaceutically acceptable salts thereof are useful for the control or prevent of acute and/or chronic neurological disorders wherein: R is halogen or alkyl; n is 0-3; R1 is alkyl, cycloalkyl, optionally substituted benzyl, alkoxy or alkyl, optionally substituted benzoyl, acetyl or cycloalkyl-carbonyl and Ring A is an aromatic 5-membered residue which is bonded via a N atom and which contains further 1-3 N atoms in addition to the linking N atom.
Patent NZ-505170-A (NZ)
Title: Ignition improved fuels doped with a cyclic ketone peroxide
Inventor: DE GROOT JOHANNES JACOBUS
IPC: C10L/
Filed: 1998-12-14
Abstract: A fuel contains one or more cyclic ketone peroxides including 0.01 to 10 % weight of one or more cyclic ketone peroxides of formula I wherein R1 to R6 are independently hydrogen or optionally substituted, alkyl, cycloalkyl, aryl, aralkyl, or alkaryl provided that the peroxides of formula (I) make up at least 35% by weight of all cyclic ketone peroxides in the fuel.
Patent NZ-511608-A (NZ)
Title: Pharmaceutical compositions comprising thiazolidinedione, insulin secretagogue and biguanide for treating diabetes
Inventor: BUCKINGHAM ROBIN EDWIN
IPC: A61K45/00
Filed: 1998-07-16
Abstract: A pharmaceutical composition comprising an insulin sensitiser, an insulin secretagogue and a biguanide antihyperglycaemic agent and a pharmaceutically acceptable carrier therefor, wherein the insulin sensitiser is 2 to 12 mg of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy] benzyl]-thiazolidine-2,4-dione and wherein the insulin secretagogue is glibenclamide, glipizide, gliclazide, glimepiride, tolazamide, tolbutamide, acetohexamide, carbutamide, chlorpropamide, glibornuride, gliquidone, glisentide, glisolamide, glisoxepide, glyclopyamide, glycylamide or repaglinide.
Patent NZ-512734-A (NZ)
Title: High-strength magnesia partially stabilized zirconia containing a grain growth inhibitor
Inventor: STUART MARTIN D
IPC: C04B35/486
Filed: 2000-01-24
Abstract: A Mg-PSZ ceramic body formed from a ceramic powder composition consisting of 2.8-5.0% by weight MgO, an effective amount of grain growth inhibiting additive, and the balance being zirconia.  The crystalline microstructure of the ceramic body comprises grains of cubic zirconia having an average grain size of less than about 30 microns in major dimension and 0.1-8.7% by volume of discrete particles of the grain growth inhibiting material which is or is formed from the additive
Patent NZ-514890-A (NZ)
Title: Pregelatinized starch in a controlled release formulation
Inventor: VANDECRUYS ROGER PETRUS GEREBE
IPC: A61K47/48
Filed: 2000-03-24
Abstract: A hydrophilic controlled release formulation comprises pregelatinized starch, one or more active ingredients, one or more viscous hydrophilic polymers and optionally pharmaceutically acceptable formulating agents. The pregelatinized starch enables the formulation to maintain a controlled release of the incorporated active ingredient(s) in release media with changing ionic strength or prevents dose dumping from the formulation along the gastrointestinal tract in both fast and fed conditions provided that the active ingredient is other than conjugated estrogen, salbutamol sulphate, dihydroergotamine mono methane sulphonate, acetyl salicylic acid, diphenhydramine hydrochloride, a vitamin B1 derivative and provided that formula does not contain a peptide of at most 5 amino acids with a protective group of phenylbenzyloxycarbonyl, N-methyl, t-butyl butyloxycarbonyl, fluoroenylmethyloxycarbonyl or carbobenzoxy at the N-terminus.
Patent NZ-515781-A (NZ)
Title: Compositions and methods comprising morphine gluconate
Inventor: BEHL CHARANJIT R
IPC: A61K9/22
Filed: 2000-05-23
Abstract: A pharmaceutical composition comprises morphine sulphate and sodium gluconate. Also described is a pharmaceutical composition containing selected from morphine gluconate, D-gluconic acid, gluconic acid, glycogenic acid and glycan-D-lactone useful for eliciting an analgesic or anesthetic response in a mammal.
Patent NZ-516113-A (NZ)
Title: Electrolyte rebalancing system
Inventor: MORRISSEY PATRICK JOHN
IPC: H01M8/04
Filed: 2000-06-30
Abstract: A process for rebalancing the electrolyte system in  a regenerative fuel cell using a sulfide/polysulfide  reaction in  one  half of the cell and a bromine/bromide reaction  in the   other   half  of  the  cell  comprises   passing   the electrolyte      containing      sulfide/polysulfide      or bromine/bromide through the + chamber of an  auxiliary  cell and  passing an electrolyte containing water and being  free from  polysulfide or bromine through the -  chamber  of  the auxiliary  cell,  the  auxiliary cell  operating  so  as  to oxidise  sulfide ions to sulfur or bromide ions  to  bromine in  the  +  chamber  and  to reduce water  to  hydrogen  and hydroxide ions in the - chamber.
Patent NZ-517644-A (NZ)
Title: Regioselective synthesis of rapamycin derivatives
Inventor: SHAW CHIA-CHENG
IPC: C07F7/18
Filed: 2000-09-27
Abstract: A process for preparing rapamycin 31-silyl ether, which comprises: (a)  reacting  rapamycin  with a silylating  agent  to  form rapamycin 31,42-bis-silyl ether; and (b)  hydrolysing the 31,42-bis-silyl ether with cold  dilute acid to provide rapamycin 31-silyl ether.
Patent NZ-518586-A (NZ)
Title: Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions
Inventor: WEICHERT ANDREAS
IPC: A61K31/415
Filed: 2000-10-14
Abstract: The use of compound I (see below) is discussed where: * R1 is a straight-chain or branched C1-8alkyl or phenyl-(CH2)m * m is zero, 1 or 2 where the phenyl nucleus is unsubstituted or carries one to three substituents from the groups F, Cl, CH3 or CH3O * R2 and R3 are straight chain or branched C1-C6 alkyl or phenyl, where the phenyl nucleus is unsubstituted or carries one to three substituents from the groups F, Cl, CH3 or CH3O * Or R2 and R3 can together form a (C5-C6) ring to which phenyl rings are fused. The compound as discussed above may be used for the production of a medicament for the treatment or prophylaxis of cardiac infarct, angina pectoris, conditions of peripheral and central nervous system and stroke.